title: Type A aortic dissection in a patient on dabigatran: hemostasis post circulatory arrest.
abstract: We present a successful case of prevention of postoperative hemorrhage in a 70-year-old male on dabigatran, who developed an acute type A aortic dissection and subsequently underwent an emergent ascending aortic replacement.
authors.affiliation: Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: eashikhmina@partners.org.
authors.forename: Elena
authors.initials: E
authors.lastname: Ashikhmina
authors.affiliation: Department of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Nicole
authors.initials: N
authors.lastname: Tomasello
authors.affiliation: Division of Hematology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Jean Marie
authors.initials: JM
authors.lastname: Connors
authors.affiliation: Department of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Jama
authors.initials: J
authors.lastname: Jahanyar
authors.affiliation: Department of Cardiac Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: Michael
authors.initials: M
authors.lastname: Davidson
authors.affiliation: Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: K Annette
authors.initials: KA
authors.lastname: Mizuguchi
mesh_terms: D000368:Aged; D000784:Aortic Dissection / Q000601:surgery*; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D017545:Aortic Aneurysm, Thoracic / Q000601:surgery*; D001562:Benzimidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D000069604:Dabigatran; D006489:Hemostatic Techniques; D006801:Humans; D008297:Male; D019106:Postoperative Hemorrhage / Q000139:chemically induced* / Q000628:therapy; D014656:Vascular Surgical Procedures / Q000379:methods*; D015091:beta-Alanine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D000069604:Dabigatran